Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial.

Abstract:

:Inhaled iloprost is an effective therapy for patients with pulmonary arterial hypertension (PAH); however, some patients experience extended inhalation times when using the V10 formulation (10.0 µg/mL) to deliver a 5 -µg dose (at mouthpiece) and are at risk of incomplete inhalations and reduced inhalation frequency. VENTASWITCH was an observational, case-crossover study to evaluate inhalation behavior in patients with PAH switched from iloprost V10 to V20 (20.0 µg/mL) formulation for delivering a 5 -µg dose using the I-Neb® AAD® device. Adults with PAH participating in a German Ventavis® (iloprost) patient-support program, who were switched from the V10 to V20 formulation, were enrolled. The co-primary endpoints were mean daily proportion of complete inhalations and mean daily inhalation frequency. The secondary endpoint was mean daily inhalation duration. Data were collected for three months before and after switching. Overall, 63 patients were included. Switching from V10 to V20 resulted in a significant increase in the mean daily proportion of complete inhalations (92% vs. 97%, P < 0.0001) and inhalation frequency (4.6 vs. 4.9 inhalations/day, P = 0.0430), and reduction in mean inhalation duration (11.8 vs. 6.5 min; P < 0.0001). Greater increases in daily proportions of complete inhalations were observed in older patients (≥ 65 vs. < 65 years) and those receiving more (3 vs. < 3) concomitant PAH medications. Switching from V10 to V20 iloprost formulation significantly improved inhalation behavior in patients with PAH and may facilitate improved adherence to therapy.

journal_name

Pulm Circ

journal_title

Pulmonary circulation

authors

Richter MJ,Stollfuß B,Roitenberg A,Kleinjung F,Graeff V,Berghaus S,Müller C,Ghofrani HA

doi

10.1177/2045894018798921

subject

Has Abstract

pub_date

2018-10-01 00:00:00

pages

2045894018798921

issue

4

eissn

2045-8932

issn

2045-8940

journal_volume

8

pub_type

杂志文章
  • BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series).

    abstract::Despite the discovery more than 15 years ago that patients with hereditary pulmonary arterial hypertension (HPAH) inherit BMP type 2 receptor ( BMPR2) mutations, it is still unclear how these mutations cause disease. In part, this is attributable to the rarity of HPAH and difficulty obtaining tissue samples from patie...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018765840

    authors: Frump A,Prewitt A,de Caestecker MP

    更新日期:2018-04-01 00:00:00

  • Echocardiographic assessment of right ventricular function in experimental pulmonary hypertension.

    abstract::Echocardiography, a non-invasive and cost-effective method for monitoring cardiac function, is commonly used for evaluation and pre-clinical diagnostics of pulmonary hypertension (PH). Previous echocardiographic studies in experimental models of PH are fragmentary in terms of the evaluation of right ventricle (RV) fun...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894019841987

    authors: Zhu Z,Godana D,Li A,Rodriguez B,Gu C,Tang H,Minshall RD,Huang W,Chen J

    更新日期:2019-04-01 00:00:00

  • Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets.

    abstract::The development of pulmonary arterial hypertension (PAH) in pediatric patients has been linked to the production of the arachidonic acid metabolite, thromboxane A(2) (TxA(2)). The present study evaluated the therapeutic effect of furegrelate sodium, a thromboxane synthase inhibitor, on the development of PAH in a neon...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.97605

    authors: Hirenallur-S DK,Detweiler ND,Haworth ST,Leming JT,Gordon JB,Rusch NJ

    更新日期:2012-04-01 00:00:00

  • Substrate stiffness-dependent exacerbation of endothelial permeability and inflammation: mechanisms and potential implications in ALI and PH (2017 Grover Conference Series).

    abstract::The maintenance of endothelial barrier integrity is absolutely essential to prevent the vascular leak associated with pneumonia, pulmonary edema resulting from inhalation of toxins, acute elevation to high altitude, traumatic and septic lung injury, acute lung injury (ALI), and its life-threatening complication, acute...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018773044

    authors: Karki P,Birukova AA

    更新日期:2018-04-01 00:00:00

  • Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension.

    abstract::Pathological alterations of inspiratory capacity (IC) have been observed in pulmonary hypertension. However, the clinical significance of IC in operable chronic thromboembolic pulmonary hypertension (CTEPH) without other pulmonary diseases remains unknown. CTEPH patients scheduled for pulmonary endarterectomy were pro...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045893217709763

    authors: Richter MJ,Gall H,Wittkämper G,Seeger W,Mayer E,Ghofrani HA,Guth S,Reichenberger F

    更新日期:2017-04-01 00:00:00

  • Dosing characteristics of oral treprostinil in real-world clinical practice.

    abstract::Pharmacokinetic studies with oral treprostinil demonstrate that three times daily (TID) dosing reduces peak-to-trough plasma trepostinil fluctuations compared with twice daily (BID) dosing. TID dosing may allow for faster titration, higher total daily doses, and potentially improve the tolerability of oral trepostinil...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018770654

    authors: Balasubramanian VP,Messick CR,Broderick M,Nelsen AC

    更新日期:2018-04-01 00:00:00

  • The genetics of pulmonary arterial hypertension in the post-BMPR2 era.

    abstract::Pulmonary arterial hypertension (PAH) is a rapidly progressive and fatal disease for which there is an ever-expanding body of genetic and related pathophysiological information on disease pathogenesis. The most common single culprit gene known is BMPR2, and animal models of the disease in several forms exist. There is...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.87293

    authors: Fessel JP,Loyd JE,Austin ED

    更新日期:2011-07-01 00:00:00

  • Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension.

    abstract::Atrial arrhythmias are common during episodes of acute respiratory failure in patients with chronic lung disease-associated pulmonary hypertension. Expert opinion suggests that management of atrial arrhythmias in patients with pulmonary hypertension should aim to restore sinus rhythm. This is clinically challenging in...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.1177/2045894020910685

    authors: Vahdatpour CA,Luebbert JJ,Palevsky HI

    更新日期:2020-03-09 00:00:00

  • Low-grade albuminuria in pulmonary arterial hypertension.

    abstract::Low-grade albuminuria, determined by the urinary albumin to creatinine ratio, has been linked to systemic vascular dysfunction and is associated with cardiovascular mortality. Pulmonary arterial hypertension is related to mutations in the bone morphogenetic protein receptor type 2, pulmonary vascular dysfunction and i...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018824564

    authors: Nickel NP,de Jesus Perez VA,Zamanian RT,Fessel JP,Cogan JD,Hamid R,West JD,de Caestecker MP,Yang H,Austin ED

    更新日期:2019-04-01 00:00:00

  • Effects of dose and age on adverse events associated with tadalafil in the treatment of pulmonary arterial hypertension.

    abstract::There are limited data on the management of pulmonary arterial hypertension (PAH) in the elderly; therefore, this analysis compared the safety and efficacy of tadalafil between patients ≥65 and <65 years old. This was a post hoc analysis of the randomized, double-blind, placebo-controlled phase 3 Pulmonary Arterial Hy...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/674901

    authors: Berman-Rosenzweig E,Arneson C,Klinger JR

    更新日期:2014-03-01 00:00:00

  • Impact of four times daily dosing of oral treprostinil on tolerability and daily dose achieved in pulmonary hypertension.

    abstract::Oral treprostinil (TRE) is a prostacylin that is approved for the treatment of patients with pulmonary arterial hypertension (PAH). Dosing is approved for two or three times daily (t.i.d.); however, adverse effects, including gastrointestinal-related symptoms, may limit the ability to reach optimal doses. We report ou...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1177/2045893217744512

    authors: Coons JC,Bunner C,Ishizawar DC,Risbano MG,Rivera-Lebron B,Mathier MA,Chan SY,Simon MA

    更新日期:2018-01-01 00:00:00

  • Rescue therapy with thrombolysis in patients with severe COVID-19-associated acute respiratory distress syndrome.

    abstract::Acute respiratory distress syndrome in patients with Coronavirus disease 19 is associated with an unusually high incidence of pulmonary embolism and microthrombotic disease, with evidence for reduced fibrinolysis. We describe seven patients requiring invasive ventilation for COVID-19-associated acute respiratory distr...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894020973906

    authors: Price LC,Garfield B,Bleakley C,Keeling AGM,Mcfadyen C,McCabe C,Ridge CA,Wort SJ,Price S,Arachchillage DJ

    更新日期:2020-12-15 00:00:00

  • Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension.

    abstract::Insulin resistance is highly prevalent in pulmonary arterial hypertension (PAH) patients. However, the long-term impact of diabetes mellitus (DM) on survival in PAH is unclear. Insulin resistance and DM are associated with left ventricular steatosis and dysfunction, but whether the right ventricle (RV) might be affect...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/675994

    authors: Benson L,Brittain EL,Pugh ME,Austin ED,Fox K,Wheeler L,Robbins IM,Hemnes AR

    更新日期:2014-06-01 00:00:00

  • Particulate matter disrupts human lung endothelial cell barrier integrity via Rho-dependent pathways.

    abstract::Increased exposure to ambient particulate matter (PM) is associated with elevated morbidity and mortality in patients with cardiopulmonary diseases and cancer. We and others have shown that PM induces lung microvascular barrier dysfunction which potentially enhances the systemic toxicity of PM. However, the mechanisms...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/689906

    authors: Wang T,Shimizu Y,Wu X,Kelly GT,Xu X,Wang L,Qian Z,Chen Y,Garcia JGN

    更新日期:2017-07-01 00:00:00

  • Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England.

    abstract::Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of unresolved organised pulmonary emboli/thrombi obstructing the major pulmonary arteries. The aim of this study was to estimate the incidence and risk factors of CTEPH in a cohort with first venous thromboembolism (VTE). This was a population-bas...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018791358

    authors: Martinez C,Wallenhorst C,Teal S,Cohen AT,Peacock AJ

    更新日期:2018-07-01 00:00:00

  • Comparative effectiveness of oral prostacyclin pathway drugs on hospitalization in patients with pulmonary hypertension in the United States: a retrospective database analysis.

    abstract::Two oral medications targeting the prostacyclin pathway are available to treat pulmonary arterial hypertension in the United States: oral treprostinil and selexipag. We compared real-world hospitalization in patients receiving these medications. A retrospective administrative claims study was conducted using the Optum...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894020911831

    authors: McConnell JW,Tsang Y,Pruett J,Iii WD

    更新日期:2020-11-10 00:00:00

  • Effects of tetrahydrobiopterin oral treatment in hypoxia-induced pulmonary hypertension in rat.

    abstract::Endothelial nitric oxide synthase (eNOS) plays a major role in maintaining pulmonary vascular homeostasis. Tetrahydrobiopterin (BH4), an essential cofactor that stabilizes the dimerization of eNOS and balances nitric oxide (NO) and superoxide production, may have therapeutic potential in pulmonary hypertension. In the...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/677361

    authors: Francis BN,Hale A,Channon KM,Wilkins MR,Zhao L

    更新日期:2014-09-01 00:00:00

  • Retinal vascular changes and right ventricular structure and function: the MESA-Right Ventricle and MESA-Eye studies.

    abstract::Retinal vessel diameters have been associated with left ventricular morphology and function but their relationship with the right ventricle (RV) has not been studied. We hypothesized that wider retinal venules and narrower retinal arterioles are associated with RV morphology and function. RV end-diastolic mass (RVEDM)...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018819781

    authors: Chyou AC,Klein BEK,Klein R,Barr RG,Cotch MF,Praestgaard A,Wong TY,Lima J,Bluemke DA,Kawut S

    更新日期:2018-12-03 00:00:00

  • Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy.

    abstract::Pulmonary arterial hypertension (PAH) is a progressive and debilitating condition. Despite promoting vasodilation, current drugs have a therapeutic window within which they are limited by systemic side effects. Nanomedicine uses nanoparticles to improve drug delivery and/or reduce side effects. We hypothesize that thi...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045893217710224

    authors: Mohamed NA,Davies RP,Lickiss PD,Ahmetaj-Shala B,Reed DM,Gashaw HH,Saleem H,Freeman GR,George PM,Wort SJ,Morales-Cano D,Barreira B,Tetley TD,Chester AH,Yacoub MH,Kirkby NS,Moreno L,Mitchell JA

    更新日期:2017-07-01 00:00:00

  • Echocardiographic parameters of right ventricular function predict mortality in acute respiratory distress syndrome: a pilot study.

    abstract::Right ventricular (RV) dysfunction in acute respiratory distress syndrome (ARDS) contributes to increased mortality. Our aim is to identify reproducible transthoracic echocardiography (TTE) parameters of RV dysfunction that can be used to predict outcomes in ARDS. We performed a retrospective single-center cohort pilo...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/685549

    authors: Shah TG,Wadia SK,Kovach J,Fogg L,Tandon R

    更新日期:2016-06-01 00:00:00

  • Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series).

    abstract::Chronic lung disease (CLD), including pulmonary fibrosis (PF) and chronic obstructive pulmonary disease (COPD), is the fourth leading cause of mortality worldwide. Both are debilitating pathologies that impede overall tissue function. A common co-morbidity in CLD is vasculopathy, characterized by deregulated angiogene...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045893217739807

    authors: Kropski JA,Richmond BW,Gaskill CF,Foronjy RF,Majka SM

    更新日期:2018-01-01 00:00:00

  • Addition of a bilateral access form of peripheral extracorporeal membrane oxygenation rescued a patient with idiopathic pulmonary arterial hypertension who developed circulatory collapse immediately after childbirth.

    abstract::Pregnancy is not advised for patients with Pulmonary hypertension (PH) because of high risk of PH crisis. However, some patients have undiagnosed idiopathic pulmonary arterial hypertension (IPAH) before pregnancy. Upfront combination therapy has high efficacy for patients with IPAH. However, some patients are unable t...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1177/2045894020910140

    authors: Adachi S,Shimokata S,Yoshida M,Imai R,Nakano Y,Okumura N,Suzuki S,Murohara T,Kondo T

    更新日期:2020-02-28 00:00:00

  • Determinants of right ventricular afterload (2013 Grover Conference series).

    abstract::Right ventricular (RV) afterload consists of both resistive and capacitive (pulsatile) components. Total afterload can be measured directly with pulmonary artery input impedance spectra or estimated, either with lumped-parameter modeling or by pressure-volume analysis. However, the inverse, hyperbolic relationship bet...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.1086/676020

    authors: Tedford RJ

    更新日期:2014-06-01 00:00:00

  • Advancing clinical trial design in pulmonary hypertension.

    abstract::In pulmonary hypertension, as in many other diseases, there is a need for a smarter approach to evaluating new treatments. The traditional randomized controlled trial has served medical science well, but constrains the development of treatments for rare diseases. A workshop was established to consider alternative clin...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.109933

    authors: Grieve AP,Chow SC,Curram J,Dawe S,Harnisch LO,Henig NR,Hung HM,Ivy DD,Kawut SM,Rahbar MH,Xiao S,Wilkins MR

    更新日期:2013-01-01 00:00:00

  • Molecular and functional significance of Ca(2+)-activated Cl(-) channels in pulmonary arterial smooth muscle.

    abstract::Increased peripheral resistance of small distal pulmonary arteries is a hallmark signature of pulmonary hypertension (PH) and is believed to be the consequence of enhanced vasoconstriction to agonists, thickening of the arterial wall due to remodeling, and increased thrombosis. The elevation in arterial tone in PH is ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.1086/680189

    authors: Leblanc N,Forrest AS,Ayon RJ,Wiwchar M,Angermann JE,Pritchard HA,Singer CA,Valencik ML,Britton F,Greenwood IA

    更新日期:2015-06-01 00:00:00

  • Transforming growth factor-β inhibition and endothelin receptor blockade in rats with monocrotaline-induced pulmonary hypertension.

    abstract::Transforming growth factor-β (TGF-β) inhibition is an investigational therapy for pulmonary arterial hypertension with promising results in experimental studies. The present work compared this approach with endothelin-receptor blockade and evaluated the effects of combined administration. Pulmonary arterial hypertensi...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.105034

    authors: Megalou AJ,Glava C,Vilaeti AD,Oikonomidis DL,Baltogiannis GG,Papalois A,Vlahos AP,Kolettis TM

    更新日期:2012-10-01 00:00:00

  • Dynamic right ventricular-pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension.

    abstract::Despite recent advances, the prognosis of pulmonary hypertension (PH) remains poor. While the initial insult in PH implicates the pulmonary vasculature, the functional state, exercise capacity, and survival of such patients are closely linked to right ventricular (RV) function. In the current study, we sought to inves...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894019862435

    authors: Singh I,Rahaghi FN,Naeije R,Oliveira RKF,Vanderpool RR,Waxman AB,Systrom DM

    更新日期:2019-07-01 00:00:00

  • Novel approach to classifying patients with pulmonary arterial hypertension using cluster analysis.

    abstract::Pulmonary arterial hypertension (PAH) patients have distinct disease courses and responses to treatment, but current diagnostic and treatment schemes provide limited insight. We aimed to see if cluster analysis could distinguish clinical phenotypes in PAH. An unbiased cluster analysis was performed on 17 baseline clin...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045893217705891

    authors: Parikh KS,Rao Y,Ahmad T,Shen K,Felker GM,Rajagopal S

    更新日期:2017-04-01 00:00:00

  • Change in R wave in lead V1 predicts survival of patients with pulmonary arterial hypertension.

    abstract::Clinical guidelines for pulmonary hypertension recommend evaluating treatment response through various methods; however, electrocardiography (ECG) is not included as one of the methods of choice. We aimed to identify ECG parameters that correlated with prognosis in patients with pulmonary arterial hypertension (PAH). ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018776496

    authors: Sato S,Ogawa A,Matsubara H

    更新日期:2018-04-01 00:00:00

  • Reducing rates of readmission and development of an outpatient management plan in pulmonary hypertension: lessons from congestive heart failure management.

    abstract::Pulmonary hypertension currently has minimal guidelines for outpatient disease management. Congestive heart failure studies, however, have shown effectiveness of disease management plans in reducing all-cause mortality and all-cause and congestive heart failure-related hospital readmissions. Heart failure exacerbation...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894020968471

    authors: Dolan J,Mandras S,Mehta JP,Navas V,Tarver J,Chakinala M,Rahaghi F

    更新日期:2020-12-07 00:00:00